|
Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer, Phase III (SWOG 9346):
- Diagnosis of prostate cancer and have a clinical
Stage D2 with soft tissue and or bony mets
- Patient must have an elevated PSA greater than 5
within 56 days prior to registration
|
